These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 17606978)
1. Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function. Terawaki S; Tanaka Y; Nagakura T; Hayashi T; Shibayama S; Muroi K; Okazaki T; Mikami B; Garboczi DN; Honjo T; Minato N Int Immunol; 2007 Jul; 19(7):881-90. PubMed ID: 17606978 [TBL] [Abstract][Full Text] [Related]
2. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes. Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786 [TBL] [Abstract][Full Text] [Related]
3. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Butte MJ; Keir ME; Phamduy TB; Sharpe AH; Freeman GJ Immunity; 2007 Jul; 27(1):111-22. PubMed ID: 17629517 [TBL] [Abstract][Full Text] [Related]
4. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Wang L; Han R; Hancock WW Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549 [TBL] [Abstract][Full Text] [Related]
5. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3. Seko Y; Yagita H; Okumura K; Azuma M; Nagai R Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153 [TBL] [Abstract][Full Text] [Related]
6. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960 [TBL] [Abstract][Full Text] [Related]
7. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Ding H; Wu X; Gao W Clin Immunol; 2005 May; 115(2):184-91. PubMed ID: 15885642 [TBL] [Abstract][Full Text] [Related]
8. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943 [TBL] [Abstract][Full Text] [Related]
9. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224 [TBL] [Abstract][Full Text] [Related]
10. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells. Chen C; Qu QX; Huang JA; Zhu YB; Ge Y; Wang Q; Zhang XG Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283 [TBL] [Abstract][Full Text] [Related]
11. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts. Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome. Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694 [TBL] [Abstract][Full Text] [Related]
13. DCs sensitized with mPD-L1-Ig fusion protein improve the effect of heart transplantation in mice by promoting the generation of T-reg cells. Liu C; Chen H; Jia J; Hong T; Wang C Cell Immunol; 2014 Jul; 290(1):169-77. PubMed ID: 24997656 [TBL] [Abstract][Full Text] [Related]
14. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684 [TBL] [Abstract][Full Text] [Related]
15. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege. Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053 [TBL] [Abstract][Full Text] [Related]
16. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. Carter LL; Leach MW; Azoitei ML; Cui J; Pelker JW; Jussif J; Benoit S; Ireland G; Luxenberg D; Askew GR; Milarski KL; Groves C; Brown T; Carito BA; Percival K; Carreno BM; Collins M; Marusic S J Neuroimmunol; 2007 Jan; 182(1-2):124-34. PubMed ID: 17182110 [TBL] [Abstract][Full Text] [Related]
17. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527 [TBL] [Abstract][Full Text] [Related]
18. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Carreno BM; Collins M Annu Rev Immunol; 2002; 20():29-53. PubMed ID: 11861596 [TBL] [Abstract][Full Text] [Related]
19. Rejuvenating exhausted T cells during chronic viral infection. Okazaki T; Honjo T Cell; 2006 Feb; 124(3):459-61. PubMed ID: 16469690 [TBL] [Abstract][Full Text] [Related]
20. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Sugita S; Usui Y; Horie S; Futagami Y; Yamada Y; Ma J; Kezuka T; Hamada H; Usui T; Mochizuki M; Yamagami S Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):263-72. PubMed ID: 18775867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]